Yarlagadda S. Babu serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Yarlagadda S. Babu has executed 65 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 29, 2012 involved exercising options for 921 shares valued at $0.
Yarlagadda S. Babu currently holds 330,056 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yarlagadda S. Babu has been a net seller of BCRX stock. They have purchased $36.3K and sold $2.8M worth of shares.
Yarlagadda S. Babu's most recent insider trade was on Feb 29, 2012, when they sold 921 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 1,834 |
| $N/A |
| Discretionary |
| Feb 29, 2012 | BCRX | $0 | Option Exercise | 13,126 | $N/A | Discretionary |
| Feb 29, 2012 | BCRX | $0 | Option Exercise | 31,179 | $N/A | Discretionary |
| Feb 29, 2012 | BCRX | $0 | Option Exercise | 6,608 | $N/A | Discretionary |
| Feb 22, 2012 | BCRX | $1.3K | Option Exercise | 1,226 | $1.04 | Discretionary |
| Feb 22, 2012 | BCRX | $6.9K | Option Exercise | 5,865 | $1.18 | Discretionary |
| Feb 22, 2012 | BCRX | $28.6K | Option Exercise | 23,821 | $1.20 | Discretionary |
| Feb 22, 2012 | BCRX | $130.4K | Sale | 30,912 | $4.22 | Discretionary |
| Mar 1, 2011 | BCRX | $0 | Award | 9,000 | $N/A | Discretionary |
| Dec 31, 2009 | BCRX | $39.6K | Payment | 6,137 | $6.46 | Discretionary |
| Oct 26, 2009 | BCRX | $69.4K | Sale | 6,400 | $10.85 | Discretionary |
| Oct 21, 2009 | BCRX | $2.0K | Sale | 200 | $10.00 | Discretionary |
| Oct 20, 2009 | BCRX | $34.0K | Sale | 3,400 | $10.00 | Discretionary |
| Sep 23, 2009 | BCRX | $182.8K | Sale | 20,000 | $9.14 | Discretionary |